180 related articles for article (PubMed ID: 37726807)
1. Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation.
Li X; Zhan F; Peng T; Xia Z; Li J
Eur J Med Res; 2023 Sep; 28(1):355. PubMed ID: 37726807
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease.
Zhang Y; Wang L; Qi J; Yu B; Zhao J; Pang L; Zhang W; Bin L
Diabetol Metab Syndr; 2023 May; 15(1):94. PubMed ID: 37158953
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.
Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS
Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745
[TBL] [Abstract][Full Text] [Related]
4. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study.
Li H; Shi Z; Chen X; Wang J; Ding J; Geng S; Sheng X; Shi S
Diabetes Metab Syndr Obes; 2023; 16():1685-1696. PubMed ID: 37309507
[TBL] [Abstract][Full Text] [Related]
6. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
[TBL] [Abstract][Full Text] [Related]
7. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
[TBL] [Abstract][Full Text] [Related]
8. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
Zeng P; Cai X; Yu X; Gong L
Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
[TBL] [Abstract][Full Text] [Related]
9. Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study.
Wang Y; Wang J; Liu L; Yang P; Deng S; Liu X; Zhao L; Wang C; Li Y
Front Endocrinol (Lausanne); 2023; 14():1137098. PubMed ID: 37223043
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between triglyceride-glucose index and non-alcoholic fatty liver disease].
Liu YT; Wang W; Tong J; Wang BY
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):451-455. PubMed ID: 34107583
[No Abstract] [Full Text] [Related]
11. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.
Zhao J; Fan H; Wang T; Yu B; Mao S; Wang X; Zhang W; Wang L; Zhang Y; Ren Z; Liang B
Cardiovasc Diabetol; 2022 Jul; 21(1):123. PubMed ID: 35778734
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
13. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
[TBL] [Abstract][Full Text] [Related]
14. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD.
Dong W; Gong Y; Zhao J; Wang Y; Li B; Yang Y
Front Endocrinol (Lausanne); 2023; 14():1281839. PubMed ID: 38260163
[TBL] [Abstract][Full Text] [Related]
15. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults.
Tang Q; Guo XG; Sun Q; Ma J
BMC Cardiovasc Disord; 2022 May; 22(1):219. PubMed ID: 35568806
[TBL] [Abstract][Full Text] [Related]
16. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
Hu H; Han Y; Cao C; He Y
J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
[TBL] [Abstract][Full Text] [Related]
18. Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study.
Wang Z; He H; Xie Y; Li J; Luo F; Sun Z; Zheng S; Yang F; Li X; Chen X; Chen Y; Sun Y
Cardiovasc Diabetol; 2024 Feb; 23(1):87. PubMed ID: 38419016
[TBL] [Abstract][Full Text] [Related]
19. Association between triglyceride-glucose index and atrial fibrillation: A retrospective observational study.
Chen S; Mei Q; Guo L; Yang X; Luo W; Qu X; Li X; Zhou B; Chen K; Zeng C
Front Endocrinol (Lausanne); 2022; 13():1047927. PubMed ID: 36568072
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
